WASHINGTON, May 15 -- National Institutes of Health has issued a notice called: Government Owned Inventions Available for License: Synergistic Interactions for Improved Cancer Treatment.
The notice was published in the Federal Register on May 15 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.
Summary: The National Cancer Institute (NCI) seeks research co-development partners and/or licensees to develop hetIL-15 in combination with other agents, such as PPARa agonists (Fenofibrate), FLT3 inhibitors (quizartinib), IL-12, or chemotherapy into a therapeutic for cancer.
For more information, contact Inquiries related to this license opportunity should be directed to: Rose Freel, Ph.D, Unit S...